Uric acid as a potential disease modifier in patients with multiple system atrophy

Ji E. Lee, Sook K. Song, Young H. Sohn, philhyu Lee

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Background: Recent studies have suggested that mitochondrial dysfunction and oxidative stress play a key role in the pathogenesis of multiple system atrophy. Methods: We evaluated the influence of serum uric acid levels on disease progression in 52 patients with multiple system atrophy using changes in the annualized Unified Multiple System Atrophy Rating Scale scores. Results: The mean annualized Unified Multiple System Atrophy Rating Scale changes were significantly lower in patients with the highest uric acid quartile compared with those with the lowest quartile (8.4 ± 5.1 vs 20.2 ± 16.0, P = .038). Serum uric acid levels had a significant negative correlation with the annualized Unified Multiple System Atrophy Rating Scale changes (r = -0.40, P = .004). Multiple linear regression analysis showed that only serum uric acid concentration was significantly correlated with the annualized Unified Multiple System Atrophy Rating Scale changes (β = -2.687, P = .011). Conclusions: These data suggest that serum uric acid may act as a potential disease modifier in multiple system atrophy.

Original languageEnglish
Pages (from-to)1533-1536
Number of pages4
JournalMovement Disorders
Volume26
Issue number8
DOIs
Publication statusPublished - 2011 Jul 1

Fingerprint

Multiple System Atrophy
Uric Acid
Serum
Disease Progression
Linear Models
Oxidative Stress
Regression Analysis

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

Cite this

Lee, Ji E. ; Song, Sook K. ; Sohn, Young H. ; Lee, philhyu. / Uric acid as a potential disease modifier in patients with multiple system atrophy. In: Movement Disorders. 2011 ; Vol. 26, No. 8. pp. 1533-1536.
@article{42e4909177c54593b3b3ddcb7f5b143a,
title = "Uric acid as a potential disease modifier in patients with multiple system atrophy",
abstract = "Background: Recent studies have suggested that mitochondrial dysfunction and oxidative stress play a key role in the pathogenesis of multiple system atrophy. Methods: We evaluated the influence of serum uric acid levels on disease progression in 52 patients with multiple system atrophy using changes in the annualized Unified Multiple System Atrophy Rating Scale scores. Results: The mean annualized Unified Multiple System Atrophy Rating Scale changes were significantly lower in patients with the highest uric acid quartile compared with those with the lowest quartile (8.4 ± 5.1 vs 20.2 ± 16.0, P = .038). Serum uric acid levels had a significant negative correlation with the annualized Unified Multiple System Atrophy Rating Scale changes (r = -0.40, P = .004). Multiple linear regression analysis showed that only serum uric acid concentration was significantly correlated with the annualized Unified Multiple System Atrophy Rating Scale changes (β = -2.687, P = .011). Conclusions: These data suggest that serum uric acid may act as a potential disease modifier in multiple system atrophy.",
author = "Lee, {Ji E.} and Song, {Sook K.} and Sohn, {Young H.} and philhyu Lee",
year = "2011",
month = "7",
day = "1",
doi = "10.1002/mds.23556",
language = "English",
volume = "26",
pages = "1533--1536",
journal = "Movement Disorders",
issn = "0885-3185",
publisher = "John Wiley and Sons Inc.",
number = "8",

}

Uric acid as a potential disease modifier in patients with multiple system atrophy. / Lee, Ji E.; Song, Sook K.; Sohn, Young H.; Lee, philhyu.

In: Movement Disorders, Vol. 26, No. 8, 01.07.2011, p. 1533-1536.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Uric acid as a potential disease modifier in patients with multiple system atrophy

AU - Lee, Ji E.

AU - Song, Sook K.

AU - Sohn, Young H.

AU - Lee, philhyu

PY - 2011/7/1

Y1 - 2011/7/1

N2 - Background: Recent studies have suggested that mitochondrial dysfunction and oxidative stress play a key role in the pathogenesis of multiple system atrophy. Methods: We evaluated the influence of serum uric acid levels on disease progression in 52 patients with multiple system atrophy using changes in the annualized Unified Multiple System Atrophy Rating Scale scores. Results: The mean annualized Unified Multiple System Atrophy Rating Scale changes were significantly lower in patients with the highest uric acid quartile compared with those with the lowest quartile (8.4 ± 5.1 vs 20.2 ± 16.0, P = .038). Serum uric acid levels had a significant negative correlation with the annualized Unified Multiple System Atrophy Rating Scale changes (r = -0.40, P = .004). Multiple linear regression analysis showed that only serum uric acid concentration was significantly correlated with the annualized Unified Multiple System Atrophy Rating Scale changes (β = -2.687, P = .011). Conclusions: These data suggest that serum uric acid may act as a potential disease modifier in multiple system atrophy.

AB - Background: Recent studies have suggested that mitochondrial dysfunction and oxidative stress play a key role in the pathogenesis of multiple system atrophy. Methods: We evaluated the influence of serum uric acid levels on disease progression in 52 patients with multiple system atrophy using changes in the annualized Unified Multiple System Atrophy Rating Scale scores. Results: The mean annualized Unified Multiple System Atrophy Rating Scale changes were significantly lower in patients with the highest uric acid quartile compared with those with the lowest quartile (8.4 ± 5.1 vs 20.2 ± 16.0, P = .038). Serum uric acid levels had a significant negative correlation with the annualized Unified Multiple System Atrophy Rating Scale changes (r = -0.40, P = .004). Multiple linear regression analysis showed that only serum uric acid concentration was significantly correlated with the annualized Unified Multiple System Atrophy Rating Scale changes (β = -2.687, P = .011). Conclusions: These data suggest that serum uric acid may act as a potential disease modifier in multiple system atrophy.

UR - http://www.scopus.com/inward/record.url?scp=79960592809&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960592809&partnerID=8YFLogxK

U2 - 10.1002/mds.23556

DO - 10.1002/mds.23556

M3 - Article

VL - 26

SP - 1533

EP - 1536

JO - Movement Disorders

JF - Movement Disorders

SN - 0885-3185

IS - 8

ER -